Literature DB >> 20405326

Surgical resection of high-risk hepatocellular carcinoma: patient selection, preoperative considerations, and operative technique.

Mark J Truty1, Jean-Nicolas Vauthey.   

Abstract

Hepatocellular carcinoma remains a leading cause of cancer death worldwide. There are an increasing number of patients that do not meet traditional criteria for surgical resection as a result of historically poor outcomes. We define these oncologically high-risk patients as those with either one of these risk factors or a combination of them: large (>5 cm) primary tumors, multinodular disease, and/or major vascular invasion. With appropriate selection and preparation, long-term survival is possible in this subset of patients after resection. This review focuses on the surgical treatment of these high-risk patients, focusing on our own institution's approach and methods as well as reviewing the literature pertinent to the support of our current practice.

Entities:  

Mesh:

Year:  2010        PMID: 20405326      PMCID: PMC4103783          DOI: 10.1245/s10434-010-0976-5

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  53 in total

1.  Results of hepatic resection for hepatocellular carcinoma invading major portal and/or hepatic veins.

Authors:  Iwao Ikai; Yuzo Yamamoto; Naritaka Yamamoto; Hiroaki Terajima; Etsuro Hatano; Yasuyuki Shimahara; Yoshio Yamaoka
Journal:  Surg Oncol Clin N Am       Date:  2003-01       Impact factor: 3.495

Review 2.  Histological grading and staging of chronic hepatitis.

Authors:  K Ishak; A Baptista; L Bianchi; F Callea; J De Groote; F Gudat; H Denk; V Desmet; G Korb; R N MacSween
Journal:  J Hepatol       Date:  1995-06       Impact factor: 25.083

3.  The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence.

Authors:  B Ringe; C Wittekind; W O Bechstein; H Bunzendahl; R Pichlmayr
Journal:  Ann Surg       Date:  1989-01       Impact factor: 12.969

4.  Recurrence of hepatocellular carcinoma after surgery.

Authors:  J Yamamoto; T Kosuge; T Takayama; K Shimada; S Yamasaki; H Ozaki; N Yamaguchi; M Makuuchi
Journal:  Br J Surg       Date:  1996-09       Impact factor: 6.939

5.  Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma.

Authors:  Taku Aoki; Hiroshi Imamura; Kiyoshi Hasegawa; Akira Matsukura; Keiji Sano; Yasuhiko Sugawara; Norihiro Kokudo; Masatoshi Makuuchi
Journal:  Arch Surg       Date:  2004-07

6.  Long-term results after resection of hepatocellular carcinoma: experience of 480 cases.

Authors:  T Kosuge; M Makuuchi; T Takayama; J Yamamoto; K Shimada; S Yamasaki
Journal:  Hepatogastroenterology       Date:  1993-08

7.  Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure.

Authors:  J Bruix; A Castells; J Bosch; F Feu; J Fuster; J C Garcia-Pagan; J Visa; C Bru; J Rodés
Journal:  Gastroenterology       Date:  1996-10       Impact factor: 22.682

8.  Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years.

Authors:  N Nagasue; H Kohno; Y C Chang; H Taniura; A Yamanoi; M Uchida; T Kimoto; Y Takemoto; T Nakamura; H Yukaya
Journal:  Ann Surg       Date:  1993-04       Impact factor: 12.969

9.  Sampling variability of liver fibrosis in chronic hepatitis C.

Authors:  Pierre Bedossa; Delphine Dargère; Valerie Paradis
Journal:  Hepatology       Date:  2003-12       Impact factor: 17.425

10.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.

Authors:  V Mazzaferro; E Regalia; R Doci; S Andreola; A Pulvirenti; F Bozzetti; F Montalto; M Ammatuna; A Morabito; L Gennari
Journal:  N Engl J Med       Date:  1996-03-14       Impact factor: 176.079

View more
  32 in total

1.  Cost-effectiveness of Stereotactic Body Radiation Therapy versus Radiofrequency Ablation for Hepatocellular Carcinoma: A Markov Modeling Study.

Authors:  Erqi L Pollom; Kyueun Lee; Ben Y Durkee; Madeline Grade; Daniel A Mokhtari; Daniel R Wahl; Mary Feng; Nishita Kothary; Albert C Koong; Douglas K Owens; Jeremy Goldhaber-Fiebert; Daniel T Chang
Journal:  Radiology       Date:  2017-01-03       Impact factor: 11.105

2.  Integrating recent data in managing adverse events in the treatment of hepatocellular carcinoma.

Authors:  Robert G Gish; Ghassan K Abou-Alfa; Myron J Tong
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-09

3.  Artificial neural network model for predicting 5-year mortality after surgery for hepatocellular carcinoma: a nationwide study.

Authors:  Hon-Yi Shi; King-Teh Lee; Jhi-Joung Wang; Ding-Ping Sun; Hao-Hsien Lee; Chong-Chi Chiu
Journal:  J Gastrointest Surg       Date:  2012-08-10       Impact factor: 3.452

Review 4.  Comparison of outcomes of transplantation and resection in patients with early hepatocellular carcinoma: a meta-analysis.

Authors:  Mashaal Dhir; Elizabeth R Lyden; Lynette M Smith; Chandrakanth Are
Journal:  HPB (Oxford)       Date:  2012-06-19       Impact factor: 3.647

5.  Early predictor of mortality due to irreversible posthepatectomy liver failure in patients with hepatocellular carcinoma.

Authors:  Sung Hoon Kim; Dae Ryong Kang; Jae Gil Lee; Do Young Kim; Sang Hoon Ahn; Kwang-Hyub Han; Chae Yoon Chon; Kyung Sik Kim
Journal:  World J Surg       Date:  2013-05       Impact factor: 3.352

6.  A randomized phase II study of autologous cytokine-induced killer cells in treatment of hepatocellular carcinoma.

Authors:  Xiaozhou Yu; Hua Zhao; Liang Liu; Shui Cao; Baozhu Ren; Naining Zhang; Xiumei An; Jinpu Yu; Hui Li; Xiubao Ren
Journal:  J Clin Immunol       Date:  2013-12-15       Impact factor: 8.317

7.  A Novel Score Predicts HBV-Related Hepatocellular Carcinoma Recurrence After Hepatectomy: a Retrospective Multicenter Study.

Authors:  Wei Qin; Li Wang; Beiyuan Hu; Shusheng Leng; Huan Tian; Huanxian Luo; Jia Yao; Xiaolong Chen; Chao Wu; Guihua Chen; Yang Yang
Journal:  J Gastrointest Surg       Date:  2018-11-16       Impact factor: 3.452

8.  Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma.

Authors:  Dong-Zhi Zhang; Xiao-Dong Wei; Xiao-Peng Wang
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

9.  Efficacy of Nucleoside Analogs for Chronic Hepatitis B Virus-Related Hepatocellular Carcinoma After Curative Treatment: A Meta-Analysis.

Authors:  Guangcong Zhang; Xiangnan Yu; Peng Liu; Xiaoxi Huang; Xuemei Jiang
Journal:  Dig Dis Sci       Date:  2018-08-23       Impact factor: 3.199

10.  Efficacy of RetroNectin-activated cytokine-induced killer cell therapy in the treatment of advanced hepatocelluar carcinoma.

Authors:  Wei Li; Yaomei Wang; Daniel B Kellner; Lingdi Zhao; Linping Xu; Quanli Gao
Journal:  Oncol Lett       Date:  2016-05-25       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.